Question 1

What is Minerva Neurosciences?

Accepted Answer

Minerva Neurosciences is a Company.

Question 2

How often does Minerva Neurosciences appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Minerva Neurosciences first tracked by Ergen?

Accepted Answer

First tracked on Apr 02, 2026.

Question 4

When was Minerva Neurosciences last mentioned in news?

Accepted Answer

Last active on Jun 01, 2026.

Question 5

What is Minerva Neurosciences's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Minerva Neurosciences in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Minerva Neurosciences?

Accepted Answer

Minerva Neurosciences forms SAB for Roluperidone (Jun 01, 2026, 6 articles).

Question 8

How did the "Minerva Neurosciences forms SAB for Roluperidone" event impact Minerva Neurosciences?

Accepted Answer

Minerva Neurosciences formed a Scientific Advisory Board to guide the development of roluperidone and its broader R&D strategy, which is expected to enhance the scientific rigor and clinical expertise applied to its drug development programs.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.